Eli Lilly and Company (LLY)

$1,010.31 -4.18 (-0.41%)
Market Cap 977.11B
Revenue (ttm) 45.04B
Net Income (ttm) 10.59B
EPS (ttm) N/A
PE Ratio 47.57
Forward PE 43.43
Profit Margin 23.51%
Debt to Equity Ratio 1.71
Volume 2,501,240
Avg Vol 3,918,204
Day's Range N/A - N/A
Shares Out 945.38M
Stochastic %K 13%
Beta 0.37
Analysts Strong Sell
Price Target $1,041.60

Company Profile

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncolog...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 317 276 2000
Address:
Lilly Corporate Center, Indianapolis, United States
dka79
dka79 Dec. 5 at 11:07 PM
$LLY 👀
0 · Reply
Swimmingincash
Swimmingincash Dec. 5 at 8:53 PM
$LLY great week, pathetic.
0 · Reply
wa7ermelon
wa7ermelon Dec. 5 at 8:32 PM
$LEXX $NVO $LLY $PFE
0 · Reply
Flabslab
Flabslab Dec. 5 at 8:25 PM
$LLY Watching this go sub 1000 as people take their profits and run! They should have split already.
0 · Reply
ndgt10
ndgt10 Dec. 5 at 8:20 PM
$LLY First time closing below the 21ema on the daily in a long time. I'm out
0 · Reply
LuckyGuy13
LuckyGuy13 Dec. 5 at 7:30 PM
$LLY Dramatic fight to keep it over $1000 over the weekend.
0 · Reply
ShadowBanningIsBad
ShadowBanningIsBad Dec. 5 at 7:17 PM
$XBI $LLY and $NVO are working with the US government to lower drug prices. Almost al the profits from drugs come from US markets. The incentive to make new drugs come from US margins. With prices in the US coming down you have to understand that Stock are over priced. Maybe $PFE and others will resist lowering prices for a little while. People need to accept the runway for a lot of Biotech is going to run out, mergers won't save stocks until the prices drop dramatically. Baby boomers are leaving at an accelerated rate, Gen X is much more informed and skeptical of common money making drugs. By all means trade the news but stop treating Biotech and drug companies as investments.
1 · Reply
ElliottwaveForecast
ElliottwaveForecast Dec. 5 at 7:05 PM
$LLY favors rally targeting 1188 It favors short term pullback into 1034.5 - 986.6 area in (4) correcting against 10.17.2025 low before continue rally in 9 swings sequence started from August low. Check out the article at https://elliottwave-forecast.com/stock-market/lly-favors-rally-targeting-1188/ #Elliottwave #LLY
0 · Reply
kindness123
kindness123 Dec. 5 at 7:04 PM
$LLY I mean ran 1100 plus and didn't take profit 🧐😅
1 · Reply
LuckyGuy13
LuckyGuy13 Dec. 5 at 6:59 PM
$LLY Clear downtrend. No point to look for reversal. GLP-1 drugs will be banned anyway. Maybe it will not be banned in 'third world countries' like India. $NVO
1 · Reply
Latest News on LLY
Meet the Supercharged Growth Stock That Could Join Apple, Nvidia, Microsoft, and Alphabet in the $2 Trillion Club by 2028

Dec 5, 2025, 11:45 AM EST - 8 hours ago

Meet the Supercharged Growth Stock That Could Join Apple, Nvidia, Microsoft, and Alphabet in the $2 Trillion Club by 2028

With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026

Dec 5, 2025, 2:30 AM EST - 17 hours ago

With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026

ASML META

Companies Cut Prices For Blockbuster Weight-Loss Drugs

Dec 3, 2025, 3:10 PM EST - 2 days ago

Companies Cut Prices For Blockbuster Weight-Loss Drugs

1 Reason to Buy Eli Lilly Hand Over Fist Before the New Year

Dec 3, 2025, 1:10 PM EST - 2 days ago

1 Reason to Buy Eli Lilly Hand Over Fist Before the New Year

U.S. FDA approves expanded indication for Lilly's Jaypirca (pirtobrutinib), the first and only non-covalent (reversible) BTK inhibitor, for adults with relapsed or refractory CLL/SLL previously treated with a covalent BTK inhibitor

Dec 3, 2025, 12:59 PM EST - 2 days ago

U.S. FDA approves expanded indication for Lilly's Jaypirca (pirtobrutinib), the first and only non-covalent (reversible) BTK inhibitor, for adults with relapsed or refractory CLL/SLL previously treated with a covalent BTK inhibitor

GXP-Storage Appoints Former Eli Lilly Global Clinical Research Executive Chris Otto to Board of Directors

Dec 3, 2025, 10:46 AM EST - 2 days ago

GXP-Storage Appoints Former Eli Lilly Global Clinical Research Executive Chris Otto to Board of Directors

2 Trillion-Dollar Dividend Stocks to Buy and Hold for 10 Years

Dec 3, 2025, 6:45 AM EST - 2 days ago

2 Trillion-Dollar Dividend Stocks to Buy and Hold for 10 Years

MSFT

Eli Lilly and Company (LLY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 2, 2025, 1:43 PM EST - 3 days ago

Eli Lilly and Company (LLY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Howard University Receives $10M Gift from Lilly Endowment to Support Efforts to Advance Over 155 Years of Black Theological Education

Dec 2, 2025, 1:22 PM EST - 3 days ago

Howard University Receives $10M Gift from Lilly Endowment to Support Efforts to Advance Over 155 Years of Black Theological Education

BA Flies on Strong Commentary, WDC & STX Price Target Hikes, LLY Boost

Dec 2, 2025, 10:30 AM EST - 3 days ago

BA Flies on Strong Commentary, WDC & STX Price Target Hikes, LLY Boost

BA STX WDC

Eli Lilly Trims Price of Popular Weight-Loss Drug on Its Site a Month After Trump Deal

Dec 1, 2025, 5:05 PM EST - 4 days ago

Eli Lilly Trims Price of Popular Weight-Loss Drug on Its Site a Month After Trump Deal

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site.

Dec 1, 2025, 5:00 PM EST - 4 days ago

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site.

16 Quality Stocks to Own for a Volatile Market

Dec 1, 2025, 1:23 PM EST - 4 days ago

16 Quality Stocks to Own for a Volatile Market

CSCO JNJ XOM

Lilly Cuts Prices for Cash Buyers of Weight-Loss Drug Zepbound

Dec 1, 2025, 10:12 AM EST - 4 days ago

Lilly Cuts Prices for Cash Buyers of Weight-Loss Drug Zepbound

Eli Lilly Lowers Weight-Loss Drug Zepbound Prices After Trump Deal

Dec 1, 2025, 9:50 AM EST - 4 days ago

Eli Lilly Lowers Weight-Loss Drug Zepbound Prices After Trump Deal

Eli Lilly's price cut, Thanksgiving box office, trouble for gravestone makers and more in Morning Squawk

Dec 1, 2025, 8:05 AM EST - 4 days ago

Eli Lilly's price cut, Thanksgiving box office, trouble for gravestone makers and more in Morning Squawk

Eli Lilly cuts Zepbound price to widen access for obesity drug

Dec 1, 2025, 8:03 AM EST - 4 days ago

Eli Lilly cuts Zepbound price to widen access for obesity drug

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

Dec 1, 2025, 8:00 AM EST - 4 days ago

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

Is Eli Lilly a Millionaire Maker?

Nov 29, 2025, 12:43 PM EST - 6 days ago

Is Eli Lilly a Millionaire Maker?

These Are 2 of the Smartest Growth Stocks to Invest $5,000 in Today

Nov 29, 2025, 11:30 AM EST - 6 days ago

These Are 2 of the Smartest Growth Stocks to Invest $5,000 in Today

MELI

S&P 500 Gains and Losses Today: Intel Soars Amid Apple Deal Rumors; Eli Lilly Stock Slides

Nov 28, 2025, 2:55 PM EST - 7 days ago

S&P 500 Gains and Losses Today: Intel Soars Amid Apple Deal Rumors; Eli Lilly Stock Slides

INTC

Don't expect much from Eli Lilly stock anymore, says Len Yaffee

Nov 28, 2025, 9:23 AM EST - 7 days ago

Don't expect much from Eli Lilly stock anymore, says Len Yaffee

Prediction: This Growth Stock Could Hit a $2 Trillion Valuation by 2031

Nov 27, 2025, 7:18 AM EST - 8 days ago

Prediction: This Growth Stock Could Hit a $2 Trillion Valuation by 2031

Hard for Eli Lilly to move significantly higher from here in the short-term: Kessef Capital's Yaffee

Nov 26, 2025, 6:19 PM EST - 9 days ago

Hard for Eli Lilly to move significantly higher from here in the short-term: Kessef Capital's Yaffee

Stock Split Watch: Is Eli Lilly Next?

Nov 26, 2025, 10:30 AM EST - 9 days ago

Stock Split Watch: Is Eli Lilly Next?

Wall Street Breakfast Podcast: HP Downsizes To Power Up

Nov 26, 2025, 6:50 AM EST - 9 days ago

Wall Street Breakfast Podcast: HP Downsizes To Power Up

HPQ NVO

Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium

Nov 24, 2025, 4:30 PM EST - 11 days ago

Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium

Eli Lilly is better at executing now than Novo Nordisk, says BMO's Evan Seigerman

Nov 24, 2025, 2:12 PM EST - 11 days ago

Eli Lilly is better at executing now than Novo Nordisk, says BMO's Evan Seigerman

Josh Brown's ‘best stocks in the market': Health Care

Nov 24, 2025, 1:50 PM EST - 11 days ago

Josh Brown's ‘best stocks in the market': Health Care

A MTD TMO XLV

This Healthcare Company Just Touched $1 Trillion in Market Cap. Should You Invest $1,000?

Nov 24, 2025, 12:35 PM EST - 11 days ago

This Healthcare Company Just Touched $1 Trillion in Market Cap. Should You Invest $1,000?

Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting

Nov 24, 2025, 12:00 PM EST - 11 days ago

Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting

Eli Lilly Stock Joins $1 Trillion Club: What Is Happening?

Nov 24, 2025, 11:50 AM EST - 11 days ago

Eli Lilly Stock Joins $1 Trillion Club: What Is Happening?

Eli Lilly: Moving To 'Strong Buy' Rating On Revenue Growth Beyond Zepbound

Nov 24, 2025, 6:31 AM EST - 11 days ago

Eli Lilly: Moving To 'Strong Buy' Rating On Revenue Growth Beyond Zepbound

2 Top Dividend Stocks for Growth-Oriented Investors

Nov 23, 2025, 2:05 PM EST - 12 days ago

2 Top Dividend Stocks for Growth-Oriented Investors

GOOG GOOGL

2 Major Stocks Want to Dominate the GLP-1 Market. Which One Looks Like the Leader Heading Into 2026?

Nov 22, 2025, 6:13 PM EST - 13 days ago

2 Major Stocks Want to Dominate the GLP-1 Market. Which One Looks Like the Leader Heading Into 2026?

NVO

Eli Lilly Stock Value Tops $1 Trillion. Learn Why And If To Buy $LLY

Nov 22, 2025, 11:10 AM EST - 13 days ago

Eli Lilly Stock Value Tops $1 Trillion. Learn Why And If To Buy $LLY

Eli Lilly: The Weight-Loss Leader With More Upside If Execution Holds

Nov 22, 2025, 5:44 AM EST - 13 days ago

Eli Lilly: The Weight-Loss Leader With More Upside If Execution Holds

When Investors Panic, I Buy Eli Lilly

Nov 22, 2025, 4:14 AM EST - 13 days ago

When Investors Panic, I Buy Eli Lilly

The Score: Nvidia, Constellation, Eli Lilly, Gap and More Stocks That Defined the Week

Nov 21, 2025, 5:16 PM EST - 14 days ago

The Score: Nvidia, Constellation, Eli Lilly, Gap and More Stocks That Defined the Week

NVDA CEG GAP

LLY Becomes Biggest Healthcare Company: Analyzing Stock's Stunning Rally

Nov 21, 2025, 4:00 PM EST - 14 days ago

LLY Becomes Biggest Healthcare Company: Analyzing Stock's Stunning Rally

Eli Lilly becomes first health-care company to hit $1 trillion

Nov 21, 2025, 3:11 PM EST - 14 days ago

Eli Lilly becomes first health-care company to hit $1 trillion

3 Weight-Loss Drug Stocks To Consider For 2026

Nov 21, 2025, 1:58 PM EST - 14 days ago

3 Weight-Loss Drug Stocks To Consider For 2026

NVO VKTX

AI Stocks Are Taking a Beating. What to Buy Instead.

Nov 21, 2025, 1:13 PM EST - 14 days ago

AI Stocks Are Taking a Beating. What to Buy Instead.

AKAM AMZN BIIB EXPE

How to play Eli Lilly stock as it hits a much-anticipated milestone?

Nov 21, 2025, 12:17 PM EST - 14 days ago

How to play Eli Lilly stock as it hits a much-anticipated milestone?

Lilly becomes first healthcare firm to join trillion-dollar club, Wall Street reacts

Nov 21, 2025, 11:52 AM EST - 14 days ago

Lilly becomes first healthcare firm to join trillion-dollar club, Wall Street reacts

Eli Lilly's Market Cap Breaks $1 Trillion After Climbing $400 Billion in 3 Months

Nov 21, 2025, 11:29 AM EST - 14 days ago

Eli Lilly's Market Cap Breaks $1 Trillion After Climbing $400 Billion in 3 Months

Zepbound maker Eli Lilly hits $1T market cap — becoming first drug company to reach milestone

Nov 21, 2025, 11:14 AM EST - 14 days ago

Zepbound maker Eli Lilly hits $1T market cap — becoming first drug company to reach milestone

This Month's Stock Trend Hasn't Been AI. Here's What's Been Climbing Instead

Nov 21, 2025, 11:05 AM EST - 14 days ago

This Month's Stock Trend Hasn't Been AI. Here's What's Been Climbing Instead

REGN

Wall Street's new darling: Eli Lilly becomes healthcare's first $1 trillion powerhouse

Nov 21, 2025, 10:45 AM EST - 14 days ago

Wall Street's new darling: Eli Lilly becomes healthcare's first $1 trillion powerhouse

Is GLP-1 the new AI? Drugmaker Eli Lilly briefly joined the $1 trillion market cap club.

Nov 21, 2025, 10:40 AM EST - 14 days ago

Is GLP-1 the new AI? Drugmaker Eli Lilly briefly joined the $1 trillion market cap club.

dka79
dka79 Dec. 5 at 11:07 PM
$LLY 👀
0 · Reply
Swimmingincash
Swimmingincash Dec. 5 at 8:53 PM
$LLY great week, pathetic.
0 · Reply
wa7ermelon
wa7ermelon Dec. 5 at 8:32 PM
$LEXX $NVO $LLY $PFE
0 · Reply
Flabslab
Flabslab Dec. 5 at 8:25 PM
$LLY Watching this go sub 1000 as people take their profits and run! They should have split already.
0 · Reply
ndgt10
ndgt10 Dec. 5 at 8:20 PM
$LLY First time closing below the 21ema on the daily in a long time. I'm out
0 · Reply
LuckyGuy13
LuckyGuy13 Dec. 5 at 7:30 PM
$LLY Dramatic fight to keep it over $1000 over the weekend.
0 · Reply
ShadowBanningIsBad
ShadowBanningIsBad Dec. 5 at 7:17 PM
$XBI $LLY and $NVO are working with the US government to lower drug prices. Almost al the profits from drugs come from US markets. The incentive to make new drugs come from US margins. With prices in the US coming down you have to understand that Stock are over priced. Maybe $PFE and others will resist lowering prices for a little while. People need to accept the runway for a lot of Biotech is going to run out, mergers won't save stocks until the prices drop dramatically. Baby boomers are leaving at an accelerated rate, Gen X is much more informed and skeptical of common money making drugs. By all means trade the news but stop treating Biotech and drug companies as investments.
1 · Reply
ElliottwaveForecast
ElliottwaveForecast Dec. 5 at 7:05 PM
$LLY favors rally targeting 1188 It favors short term pullback into 1034.5 - 986.6 area in (4) correcting against 10.17.2025 low before continue rally in 9 swings sequence started from August low. Check out the article at https://elliottwave-forecast.com/stock-market/lly-favors-rally-targeting-1188/ #Elliottwave #LLY
0 · Reply
kindness123
kindness123 Dec. 5 at 7:04 PM
$LLY I mean ran 1100 plus and didn't take profit 🧐😅
1 · Reply
LuckyGuy13
LuckyGuy13 Dec. 5 at 6:59 PM
$LLY Clear downtrend. No point to look for reversal. GLP-1 drugs will be banned anyway. Maybe it will not be banned in 'third world countries' like India. $NVO
1 · Reply
ChicagoMan
ChicagoMan Dec. 5 at 6:33 PM
$LLY They are still GLP #1!
0 · Reply
LDT79
LDT79 Dec. 5 at 6:21 PM
$NVO of course this is down with $LLY but never up
0 · Reply
Flabslab
Flabslab Dec. 5 at 6:20 PM
$LLY The bear/bull battle is on for 1000. If it goes under this could easily see 950 next week.
0 · Reply
GettnFibbywIT
GettnFibbywIT Dec. 5 at 6:18 PM
$LLY $XPH $XLV Round "psychological" 1000 trading number coming up below...Let's see what happens around there and around a corresponding 23.6% fib retracement level & the lows of Nov 17th:
1 · Reply
wa7ermelon
wa7ermelon Dec. 5 at 5:26 PM
$LEXX 🤭 👇. Quote in press release. “Discussions with PharmaCO’s human clinical development team”. ⏰ 💣 Translation: THEY’RE NOT TALKING TRIALS. THEY’RE TALKING TAKEOVER. • BUYOUT MODE ACTIVATED • FULL DATA FIRST • CLINICAL TEAM IN THE ROOM who is the mystery pharma?? Your best guess? $NVO ? $LLY ? $PFE ?
2 · Reply
TradingFUD
TradingFUD Dec. 5 at 5:20 PM
$LNTH $BIIB $XBI $LLY
0 · Reply
breakoutstock
breakoutstock Dec. 5 at 5:08 PM
$NKTR $LLY would be stupid to let this get away. The simple fact is the settlement will be $250MM if fails in P3. Or a buyout or $5B with a 60/40 split if P3 is good. It’s very simple math.
1 · Reply
ItalianNun
ItalianNun Dec. 5 at 4:03 PM
$LLY If you want a cheap play. The daily GLP pill will likely be FDA approved by March. The government wants everyone overweight to be on it so they can then give us real universal Healthcare because it will improve all diabetes 3 diseases, and even eliminate them. Already up like 35% since Oct 1.Things they think will go bye-bye: Alzheimer’s, dementia, fatty liver disease, heart attacks, strokes, PCOS, diabetes 2 and 3.Right now this is injection only.
0 · Reply
MoneyBlisss
MoneyBlisss Dec. 5 at 3:44 PM
$LLY Premiums TOO DAMN HIGH, running volume away!!!!!!! smh. 1 contract for next week is over $2300 if you get it now to trade today. $SPY
0 · Reply
Flabslab
Flabslab Dec. 5 at 3:25 PM
$LLY And there's that red again lol.
0 · Reply
stockfrank1
stockfrank1 Dec. 5 at 3:24 PM
$LLY crazy...
0 · Reply
1Kof
1Kof Dec. 5 at 3:16 PM
$LLY what the heck !!
0 · Reply